CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Sep 30, 2024. (Total: 6327 publications)

All Cancer Diabetes Economic Environmental Equity FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-19 (of 19 Records)

Query Trace: Shimabukuro TT[original query]
Outbreak of highly pathogenic avian influenza A(H5N1) viruses in U.S. dairy cattle and detection of two human cases - United States, 2024 Garg S , Reed C , Davis CT , Uyeki TM , Behravesh CB , Kniss K , Budd A , Biggerstaff M , Adjemian J , Barnes JR , Kirby MK , Basler C , Szablewski CM , Richmond-Crum M , Burns E , Limbago B , Daskalakis DC , Armstrong K , Boucher D , Shimabukuro TT , Jhung MA , Olsen SJ , Dugan V . MMWR Morb Mortal Wkly Rep 2024 73 (21) 501-505
Overview of U.S. COVID-19 vaccine safety surveillance systems Gee J , Shimabukuro TT , Su JR , Shay D , Ryan M , Basavaraju SV , Broder KR , Clark M , Buddy Creech C , Cunningham F , Goddard K , Guy H , Edwards KM , Forshee R , Hamburger T , Hause AM , Klein NP , Kracalik I , Lamer C , Loran DA , McNeil MM , Montgomery J , Moro P , Myers TR , Olson C , Oster ME , Sharma AJ , Schupbach R , Weintraub E , Whitehead B , Anderson S . Vaccine 2024
COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months-5 Years - United States, June 18, 2022-August 21, 2022. Hause AM , Marquez P , Zhang B , Myers TR , Gee J , Su JR , Parker C , Thompson D , Panchanathan SS , Shimabukuro TT , Shay DK . MMWR Morb Mortal Wkly Rep 2022 71 (35) 1115-1120
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022. Hause AM , Baggs J , Marquez P , Myers TR , Su JR , Hugueley B , Thompson D , Gee J , Shimabukuro TT , Shay DK . MMWR Morb Mortal Wkly Rep 2022 71 (33) 1047-1051
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. Oster ME , Shay DK , Su JR , Gee J , Creech CB , Broder KR , Edwards K , Soslow JH , Dendy JM , Schlaudecker E , Lang SM , Barnett ED , Ruberg FL , Smith MJ , Campbell MJ , Lopes RD , Sperling LS , Baumblatt JA , Thompson DL , Marquez PL , Strid P , Woo J , Pugsley R , Reagan-Steiner S , DeStefano F , Shimabukuro TT . JAMA 2022 327 (4) 331-340
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system. Chapin-Bardales J , Myers T , Gee J , Shay DK , Marquez P , Baggs J , Zhang B , Licata C , Shimabukuro TT . Vaccine 2021 39 (48) 7066-7073
Surveillance for Adverse Events After COVID-19 mRNA Vaccination. Klein NP , Lewis N , Goddard K , Fireman B , Zerbo O , Hanson KE , Donahue JG , Kharbanda EO , Naleway A , Nelson JC , Xu S , Yih WK , Glanz JM , Williams JTB , Hambidge SJ , Lewin BJ , Shimabukuro TT , DeStefano F , Weintraub ES . JAMA 2021 326 (14) 1390-1399
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines. Shay DK , Shimabukuro TT , DeStefano F . JAMA Cardiol 2021 6 (10) 1115-1117
Safety of the 9-Valent Human Papillomavirus Vaccine. Shimabukuro TT , Su JR , Marquez PL , Mba-Jonas A , Arana JE , Cano MV . Pediatrics 2019 144 (6)
Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017. Suragh TA , Lewis P , Arana J , Mba-Jonas A , Li R , Stewart B , Shimabukuro TT , Cano M . Br J Clin Pharmacol 2018 84 (12) 2928-2932
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015. Miller ER , Lewis P , Shimabukuro TT , Su J , Moro P , Woo EJ , Jankosky C , Cano M . Hum Vaccin Immunother 2018 14 (8) 1-23
Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015. Arana JE , Harrington T , Cano M , Lewis P , Mba-Jonas A , Rongxia L , Stewart B , Markowitz LE , Shimabukuro TT . Vaccine 2018 36 (13) 1781-1788
Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System. Arana J , Mba-Jonas A , Jankosky C , Lewis P , Moro PL , Shimabukuro TT , Cano M . J Adolesc Health 2017 61 (5) 577-582
Safety of Second-Dose Single-Antigen Varicella Vaccine. Su JR , Leroy Z , Lewis PW , Haber P , Marin M , Leung J , Woo EJ , Shimabukuro TT . Pediatrics 2017 139 (3)
Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax(®)) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015. Moro PL , Winiecki S , Lewis P , Shimabukuro TT , Cano M . Vaccine 2015 33 (48) 6684-8
Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014. Haber P , Moro PL , Cano M , Lewis P , Stewart B , Shimabukuro TT . Vaccine 2015 33 (16) 1987-92
Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013. Sukumaran L , McNeil MM , Moro PL , Lewis PW , Winiecki SK , Shimabukuro TT . Clin Infect Dis 2015 60 (10) e58-65
Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013. Moro PL , Jankosky C , Menschik D , Lewis P , Duffy J , Stewart B , Shimabukuro TT . J Pediatr 2015 166 (4) 992-7
Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013. Haber P , Moro P , McNeil MM , Lewis P , Woo EJ , Hughes H , Shimabukuro TT . Vaccine 2014 32 (48) 6499-504